Editor's Note: the "Trending USA Stocks" column tracks the day's top bullish stocks in the USA market, aiding investors in promptly identifying opportunities for potential gains.

03/07/2025 Eastern Time in USA The Dow Jones Industrial Average rose by 0.77%, closing at 44828.53 points; the Nasdaq Composite rose by 1.02%, closing at 20601.1 points; the S&P 500 Index rose by 0.83%, closing at 6279.35 points. Sahm has compiled the Top 10 Daily Stock Price Gainers in the USA market.

BitMine Immersion Technologies Inc Ordinary Shares(BMNR.US) : Overnight gain 130.8%, Secures major funding, shifts to ETH reserves, appoints crypto expert as chairman, driving stock surge.

BitMine Immersion Technologies Inc. (formerly Interactive Lighting Showrooms, Inc.) was originally incorporated in Nevada in 1995 and reincorporated in Delaware in 2020. The company has strategically pivoted to focus on long-term Bitcoin investment, primarily through mining operations and strategic acquisitions. The firm's business model involves issuing securities or raising capital to purchase Bitcoin, contingent on market conditions. Simultaneously, BitMine aims to expand its mining operations while retaining Bitcoin holdings beyond operational requirements. To finance its Bitcoin acquisitions and mining expansion, the company primarily relies on various capital-raising instruments, including common stock issuances, debt offerings, convertible notes, and preferred stock placements. This strategic shift positions BitMine Immersion Technologies Inc. as a player in the cryptocurrency mining sector, with a clear focus on Bitcoin accumulation and operational growth. The company's financing strategy demonstrates its commitment to scaling its presence in the digital asset space while maintaining flexibility in its capital structure.

BitMine Immersion Technologies Inc Ordinary Shares (BMNR) has experienced a significant surge in stock price due to multiple factors. The company recently announced the completion of a $250 million private placement, substantially bolstering its financial position. Additionally, BMNR is undergoing a strategic shift, planning to allocate the raised funds towards acquiring Ethereum (ETH) as a core reserve asset, signaling an expansion into broader cryptocurrency investments. Furthermore, renowned cryptocurrency analyst Tom Lee has been appointed as the chairman of the company's board of directors, bringing valuable industry expertise and influence. These factors, combined with the stock's low float characteristics amplifying price movements, have resulted in a 130.8% increase in BMNR's stock price over a short period, with a year-to-date gain of 610.5%.

Regencell Bioscience Holdings Ltd.(RGC.US) : Overnight gain 121.9%, Innovative TCM-biotech approach for neurological disorders drives market optimism and stock surge.

Regencell Bioscience Holdings Ltd., a biotechnology company incorporated in the Cayman Islands in 2014, specializes in the research, development, and commercialization of Traditional Chinese Medicine (TCM) for neurocognitive disorders and degenerative diseases. The company's primary focus is on Attention Deficit Hyperactivity Disorder (ADHD) and Autism Spectrum Disorder (ASD). The firm is committed to enhancing the quality of life for individuals affected by ADHD and ASD, as well as their families and caregivers. Regencell Bioscience aims to establish itself as a global market leader in the treatment of ADHD and ASD through its innovative TCM-based approaches. By leveraging its expertise in TCM and modern biotechnology, Regencell Bioscience is positioning itself to address the growing demand for alternative and complementary treatments in the neurocognitive disorder space. The company's strategic focus on ADHD and ASD aligns with the increasing prevalence of these conditions worldwide and the need for more effective therapeutic options.

Regencell Bioscience Holdings Ltd. (RGC) has experienced a significant surge in stock price, driven by multiple factors. The company's focus on developing Traditional Chinese Medicine (TCM) for neurological and degenerative disorders, particularly ADHD and ASD, positions it in a market with substantial growth potential. Investors view RGC's unique approach, combining TCM with modern biotechnology, as having breakthrough potential. The company's clear market positioning and social value have also attracted investor interest. Today's robust 121.9% gain and the staggering 17,584.6% year-to-date increase reflect the market's continued optimism about RGC's prospects. The current market capitalization of $11.357 billion further bolsters investor confidence in Regencell Bioscience's future growth and market position in the innovative pharmaceutical sector.

Enigmatig Limited(EGG.US) : Overnight gain 53.5%, New cross-border fintech firm attracts investors with global strategy and growth potential

Enigmatig Limited, an international consulting firm, was incorporated in the Cayman Islands on May 30, 2023, with its headquarters established in Singapore. The company specializes in providing comprehensive solutions for cross-border financial licensing and related services. Operating through its subsidiaries in Singapore, Hong Kong SAR, and mainland China, Enigmatig Limited offers a wide range of services, including financial license applications and compliance consulting. The firm aims to deliver comprehensive cross-border financial support to its clientele. The company's strategic positioning in key financial hubs underscores its commitment to facilitating global financial operations for its clients. By leveraging its expertise in navigating complex regulatory landscapes across multiple jurisdictions, Enigmatig Limited seeks to streamline the process of obtaining and maintaining financial licenses for businesses expanding internationally. As the demand for cross-border financial services continues to grow, Enigmatig Limited is poised to capitalize on this trend, offering tailored solutions to meet the evolving needs of its diverse client base in the global financial market.

Enigmatig Limited (EGG), a nascent cross-border financial services firm established in May 2023, has experienced a notable surge in its stock price due to multiple factors. The company's innovative business model and strategic positioning across Singapore, Hong Kong, and mainland China have garnered significant investor attention. EGG's comprehensive one-stop solution for cross-border financial licensing has been well-received by the market, indicating strong growth potential. Furthermore, the global increase in demand for cross-border financial services has bolstered investor optimism. The company's relatively small market capitalization, coupled with robust market performance—including an overnight gain of 53.5% and a year-to-date increase of 13.6%—has further attracted investor interest, contributing to the substantial rise in share price. This multifaceted growth story underscores EGG's emerging prominence in the cross-border financial services sector.

The Top 10 Daily Gainers in the USA market are listed as follows:

Editor's note: This content was generated by Sahm's in-house AI-enabled SaaS tool and was reviewed by our editing team.